Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000200406-25-000167
Filing Date
2025-07-08
Accepted
2025-07-08 17:31:26
Documents
2
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1752010278.html 3  
1 FORM 3 wk-form3_1752010278.xml 3 2174
2 EX-24.1 PINTO POA dppoa070125.htm EX-24.1 6911
  Complete submission text file 0000200406-25-000167.txt   10510
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address JPMORGAN CHASE & CO. 270 PARK AVENUE NEW YORK NY 10017
Business Address
Pinto Daniel E (Reporting) CIK: 0001555174 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-03215 | Film No.: 251111805